Immune surveillance in multiple sclerosis patients treated with natalizumab

被引:0
|
作者
Stuve, O
Marra, C
Jerome, KR
Cook, L
Cravens, PD
Cepok, S
Frohman, E
Phillips, T
Arendt, G
Hemmer, B
Monson, N
Racke, MK
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A250 / A250
页数:1
相关论文
共 50 条
  • [31] Natalizumab and Risk of Melanoma: A Prospective Follow-Up of Patients Treated by Natalizumab for Multiple Sclerosis
    Castela, Emeline
    Frenay, Christine Lebrun
    Laffon, Muriel
    Rocher, Fanny
    Passeron, Thiery
    NEUROLOGY, 2010, 74 (09) : A236 - A236
  • [32] Natalizumab and risk of melanoma: a prospective follow-up of patients treated by natalizumab for multiple sclerosis
    Castela, E.
    Lebrun, C.
    Rocher, F.
    Cohen, M.
    Passeron, T.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S231 - S231
  • [33] Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
    Heesen, Christoph
    Kleiter, Ingo
    Nguyen, Franziska
    Schaeffler, Nina
    Kasper, Juergen
    Koepke, Sascha
    Gaissmaier, Wolfgang
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1507 - 1512
  • [34] Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis
    Matos, Sara
    Cunha, Carolina
    Bernardes, Catarina
    Cardoso, Joao
    Campelo, Isabel
    Feio, Jose
    Batista, Sonia
    Nunes, Carla
    Macario, Maria do Carmo
    Sousa, Livia Maria
    Correia, Ines
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 931 - 931
  • [35] Morphea in a Multiple Sclerosis Patient Treated with Natalizumab
    Alikhani, Katayoun
    Kremenchutzky, Marcelo
    NEUROLOGY, 2010, 74 (09) : A418 - A419
  • [36] Study of the JC virus presence in multiple sclerosis patients treated with natalizumab
    Dominguez-Mozo, M. I.
    Garcia-Montojo, M.
    De las Heras, V.
    Garcia-Martinez, M. A.
    Arias-Leal, A.
    Casanova, I.
    Alvarez-Lafuente, R.
    Arroyo, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 370 - 371
  • [37] Proposed MRI Safety Monitoring of Patients with Multiple Sclerosis Treated with Natalizumab
    Vaneckova, M.
    Seidl, Z.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2016, 79 (06) : 663 - 669
  • [38] Ofatumumab as rescue therapy in multiple sclerosis patients previously treated with Natalizumab
    Chisari, Clara
    Bucello, Sebastiano
    Cottone, Salvatore
    Ragonese, Paolo
    Realmuto, Sabrina
    Ruscica, Francesca
    Toscano, Simona
    Iacono, Salvatore
    Schiro, Giuseppe
    Salemi, Giuseppe
    Grimaldi, Luigi Maria
    Patti, Francesco
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 448 - 449
  • [39] Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab
    Dallari, Simone
    Franciotta, Diego
    Carluccio, Silvia
    Signorini, Lucia
    Gastaldi, Matteo
    Colombo, Elena
    Bergamaschi, Roberto
    Elia, Francesca
    Villani, Sonia
    Ferrante, Pasquale
    Delbue, Serena
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 287 : 76 - 79
  • [40] Systematic Assessment of JC Virus in Multiple Sclerosis Patients Treated with Natalizumab
    Slesari, Iuliana
    Heinzlef, Olivier
    Poveda, Jean-Dominique
    NEUROLOGY, 2010, 74 (09) : A369 - A369